7
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
Reimagining the Future of Employer-Sponsored Health Care to Drive Value: Survey Insights
Employer-sponsored health insurance (ESI) is the most common form of health insurance in the United
States, providing coverage for approximately 180 million people, or roughly half of the US population, and accounting for more than $1 trillion in health
+ Read More
report
Employer Investments in Digital, Whole-Person Health for Substance Use Disorders
Employers seek to support their employees while normalizing a whole-person approach to substance us
e disorders (SUD). The response to addiction and the opioid crisis requires a whole-of-society approach, including employers of all sizes.
+ Read More
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
article
Milken Institute Announces Key Initiatives at the 2024 Global Conference to Shape the Future of Health
Esther Krofah, executive vice president of Milken Institute Health, (pictured at left) with Emma Wal
msley, CEO of GSK, (right) at the 2024 Milken Institute Global Conference.
+ Read More
article
Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Possible Solutions Webinar Summary
Antimicrobial resistance (AMR) poses a threat to everyone. However, some patients with chronic illne
sses are significantly more likely to become infected with antibiotic-resistant bacteria than those without chronic disease.
+ Read More